Kidney Research and Clinical Practice

Baseline characteristics of the Korean genetic cohort of inherited cystic kidney disease: Jeong Min Cho, Hayne Cho Park, Jin Woo Lee et al.; Kidney Res Clin Pract. 2023;42(5):617-627. Published online September 27, 2023; DOI: https://doi.org/10.23876/j.krcp.23.097; Full text PubReader ePub PDF Supplementary Material

Comparison of cardiovascular event predictability between the 2009 and 2021 Chronic Kidney Disease Epidemiology Collaboration equations in a Korean chronic kidney disease cohort: the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease: Ji Hye Kim, Minjung Kang, Eunjeong Kang et al.; Kidney Res Clin Pract. 2023;42(6):700-711. Published online March 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.206
Web of Science 3 Cited By 2; Full text PubReader ePub PDF Supplementary Material

Predictive performance of the new race-free Chronic Kidney Disease Epidemiology Collaboration equations for kidney outcome in Korean patients with chronic kidney disease: Hyoungnae Kim, Young Youl Hyun, Hae-Ryong Yun et al.; Kidney Res Clin Pract. 2023;42(4):501-511. Published online March 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.158
Web of Science 4 Cited By 3; Full text PubReader ePub PDF Supplementary Material

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period: Hyuk Huh, Yong Soo Kim, Wookyung Chung et al.; Kidney Res Clin Pract. 2023;42(2):216-228. Published online January 13, 2023; DOI: https://doi.org/10.23876/j.krcp.22.024
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease: Jung Nam An, Jwa-Kyung Kim, Hyung-Seok Lee, Sung Gyun Kim, Hyung Jik Kim, Young Rim Song; Kidney Res Clin Pract. 2022;41(5):580-590. Published online June 24, 2022; DOI: https://doi.org/10.23876/j.krcp.21.214
Web of Science 9 Cited By 10; Full text PubReader ePub PDF Supplementary Material

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression: Hyunsuk Kim, Jinmo Sung, Ju Young Bae, Poongyeon Lee, Yun Kyu Oh, Hyunho Kim; Kidney Res Clin Pract. 2022;41(6):730-740. Published online June 20, 2022; DOI: https://doi.org/10.23876/j.krcp.21.303
Web of Science 5 Cited By 6; Full text PubReader ePub PDF

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options: Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib; Kidney Res Clin Pract. 2022;41(4):422-431. Published online March 29, 2022; DOI: https://doi.org/10.23876/j.krcp.21.309
Web of Science 8 Cited By 10; Full text PubReader ePub PDF

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study: Hayne Cho Park, Yeji Hong, Jeong-Heum Yeon et al.; Kidney Res Clin Pract. 2022;41(4):432-441. Published online March 3, 2022; DOI: https://doi.org/10.23876/j.krcp.21.261
Web of Science 5 Cited By 6; Full text PubReader ePub PDF Supplementary Material

Incidence of acute cholecystitis underwent cholecystectomy in incidence dialysis patients: a nationwide population-based cohort study in Korea: Hanlim Choi, Soon Kil Kwon, Joung-Ho Han, Jun Su Lee, Gilwon Kang, Minseok Kang; Kidney Res Clin Pract. 2022;41(2):253-262. Published online December 13, 2021; DOI: https://doi.org/10.23876/j.krcp.20.250
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Comparison of chronic kidney disease trial designs and analysis strategies: John Lawrence; Kidney Res Clin Pract. 2021;40(1):62-68. Published online March 5, 2021; DOI: https://doi.org/10.23876/j.krcp.20.104
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

The role of the exocyst in renal ciliogenesis, cystogenesis, tubulogenesis, and development: Joshua H. Lipschutz; Kidney Res Clin Pract. 2019;38(3):260-266. Published online September 30, 2019; DOI: https://doi.org/10.23876/j.krcp.19.050
Web of Science 8 Cited By 8; Full text PubReader PDF

Cystatin C as a novel predictor of preterm labor in severe preeclampsia: Krittanont Wattanavaekin, Maethaphan Kitporntheranunt, Chatchai Kreepala; Kidney Res Clin Pract. 2018;37(4):338-346. Published online December 31, 2018; DOI: https://doi.org/10.23876/j.krcp.18.0080
Web of Science 13 Cited By 11; Full text PubReader PDF

PKD2 mutation in an Iranian autosomal dominant polycystic kidney disease family with misleading linkage analysis data^☆: Mona Entezam, Mohammad Reza Khatami, Fereshteh Saddadi, Mohsen Ayati, Jamshid Roozbeh, Mohammad Keramatipour; Kidney Res Clin Pract. 2016;35(2):96-101. Published online February 27, 2016; DOI: https://doi.org/10.1016/j.krcp.2016.02.003
Web of Science 1 Cited By 1; Full text PubReader PDF

Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease: Seung Hun Lee, Stefan Somlo; Kidney Res Clin Pract. 2014;33(2):73-78. Published online June 14, 2014; DOI: https://doi.org/10.1016/j.krcp.2014.05.002
Web of Science 36 Cited By 31; Full text PubReader PDF

Comparison of glomerular filtration rates calculated by different serum cystatin C-based equations in patients with chronic kidney disease: Hee Sun Lee, Harin Rhee, Eun Young Seong, Dong Won Lee, Soo Bong Lee, Ihm Soo Kwak; Kidney Res Clin Pract. 2014;33(1):45-51. Published online February 11, 2014; DOI: https://doi.org/10.1016/j.krcp.2013.11.001
Web of Science 6 Cited By 3; Full text PubReader PDF

15,122	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
20,032	C4d Puzzle in ABO-incompatible kidney transplantation
8,636	How should we treat acute kidney injury caused by renal congestion?
35,508	Uremic pruritus: pathophysiology, clinical presentation, and treatments
13,278	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Search